» Articles » PMID: 27532320

Carbon-Dot-Decorated Carbon Nitride Nanoparticles for Enhanced Photodynamic Therapy Against Hypoxic Tumor Via Water Splitting

Overview
Journal ACS Nano
Specialty Biotechnology
Date 2016 Aug 18
PMID 27532320
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia, a typical feature of solid tumors, remarkably restricts the efficiency of photodynamic therapy (PDT). Here, a carbon nitride (C3N4)-based multifunctional nanocomposite (PCCN) for light-driven water splitting was used to solve this problem. Carbon dots were first doped with C3N4 to enhance its red region absorption because red light could be used to trigger the in vivo water splitting process. Then, a polymer containing a protoporphyrin photosensitizer, a polyethylene glycol segment, and a targeting Arg-Gly-Asp motif was synthesized and introduced to carbon-dot-doped C3N4 nanoparticles. In vitro study showed that PCCN, thus obtained, could increase the intracellular O2 concentration and improve the reactive oxygen species generation in both hypoxic and normoxic environments upon light irradiation. Cell viability assay demonstrated that PCCN fully reversed the hypoxia-triggered PDT resistance, presenting a satisfactory growth inhibition of cancer cells in an O2 concentration of 1%. In vivo experiments also indicated that PCCN had superior ability to overcome tumor hypoxia. The use of water splitting materials exhibited great potential to improve the intratumoral oxygen level and ultimately reverse the hypoxia-triggered PDT resistance and tumor metastasis.

Citing Articles

Exploring lung cancer microenvironment: pathways and nanoparticle-based therapies.

Arandhara A, Bhuyan P, Das B Discov Oncol. 2025; 16(1):159.

PMID: 39934547 PMC: 11814423. DOI: 10.1007/s12672-025-01902-y.


AIEgen-self-assembled nanoparticles with anti-PD-L1 antibody functionalization realize enhanced synergistic photodynamic therapy and immunotherapy against malignant melanoma.

Li L, Xu Q, Zhang X, Jiang Y, Zhang L, Guo J Mater Today Bio. 2025; 30:101387.

PMID: 39742147 PMC: 11683329. DOI: 10.1016/j.mtbio.2024.101387.


Heterojunction semiconductor nanocatalysts as cancer theranostics.

Sabu A, Kandel M, Sarma R, Ramesan L, Roy E, Sharmila R APL Bioeng. 2024; 8(4):041502.

PMID: 39381587 PMC: 11459490. DOI: 10.1063/5.0223718.


Biochemical hallmarks-targeting antineoplastic nanotherapeutics.

Han J, Dong H, Zhu T, Wei Q, Wang Y, Wang Y Bioact Mater. 2024; 36:427-454.

PMID: 39044728 PMC: 11263727. DOI: 10.1016/j.bioactmat.2024.05.042.


FeO@TiO Microspheres: Harnessing O Release and ROS Generation for Combination CDT/PDT/PTT/Chemotherapy in Tumours.

Zhao B, Hu X, Chen L, Wu X, Wang D, Wang H Nanomaterials (Basel). 2024; 14(6).

PMID: 38535646 PMC: 10974882. DOI: 10.3390/nano14060498.